Cervical cancer - epidemiology, screening and treatment

被引:0
作者
Riga, Bogdan Alexandru [1 ]
机构
[1] Spitalul Clin Obstet Ginecol Prof Dr Panait Sarbu, Bucharest, Romania
来源
GINECO RO | 2008年 / 4卷 / 01期
关键词
cervical cancer; pap smear; HPV;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Most women are diagnosed with HPV on the basis of abnormal Pap smears. Pap smears are the primary screening tool for cervical cancer or pre-cancerous conditions; many of which are cell changes related to HPV Current TIPV test are fairly sophisticated and expensive and are commercially available for women with an abnormal Pap smear They cannot identify which HPV infections will, lead to cervical cancer or pre-cancerous conditions. Research is under-way. to determine the role of HPV test is for cervical cancer screening. Women with genital warts also should be examined for possible HPV infection of the cervix It is easy to identify some other invisible warts in. the genital tissue using acetic acid in the areas of suspected infection. This solution causes infected areas to whiten, which makes them more visible, particularly if a colposcopy is performed. A Pap smear test. also may indicate the possible presence of cervical TIPV infection. In a Pap smear a laboratory worker examines cells scraped from the cervix under a microscope to see if they are cancerous. If a woman Pap smear is abnormal, she might have an HPV infection. If a woman has an abnormal Pap smear she should have her doctor examine her further to look for and treat any cervical problems.
引用
收藏
页码:40 / 47
页数:8
相关论文
共 32 条
  • [1] HPV communication: Review of existing research and recommendations for patient education
    Anhang, R
    Goodman, A
    Goldie, SJ
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2004, 54 (05) : 248 - 259
  • [2] Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study
    Bjorge, T
    Engeland, A
    Luostarinen, T
    Mork, J
    Gislefoss, RE
    Jellum, E
    Koskela, P
    Lehtinen, M
    Pukkala, E
    Thoresen, SO
    Dillner, J
    [J]. BRITISH JOURNAL OF CANCER, 2002, 87 (01) : 61 - 64
  • [3] Carter JJ, 2001, CANCER RES, V61, P1934
  • [4] Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection
    Carter, JJ
    Koutsky, LA
    Hughes, JP
    Lee, SK
    Kuypers, J
    Kiviat, N
    Galloway, DA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (06) : 1911 - 1919
  • [5] A PAPILLOMAVIRUS DNA FROM A CERVICAL-CARCINOMA AND ITS PREVALENCE IN CANCER BIOPSY SAMPLES FROM DIFFERENT GEOGRAPHIC REGIONS
    DURST, M
    GISSMANN, L
    IKENBERG, H
    ZURHAUSEN, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (12): : 3812 - 3815
  • [6] HAND-GENITAL TRANSMISSION OF GENITAL WARTS - AN ANALYSIS OF PREVALENCE DATA
    FAIRLEY, CK
    GAY, NJ
    FORBES, A
    ABRAMSON, M
    GARLAND, SM
    [J]. EPIDEMIOLOGY AND INFECTION, 1995, 115 (01) : 169 - 176
  • [7] FERENCZY A, 1989, OBSTET GYNECOL, V74, P950
  • [8] Prevention of cervical cancer through papillomavirus vaccination
    Frazer, IH
    [J]. NATURE REVIEWS IMMUNOLOGY, 2004, 4 (01) : 46 - 54
  • [9] Public health paradoxes and the epidemiological impact of an HPV vaccine
    Garnett, GP
    Waddell, HC
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2000, 19 (1-2) : 101 - 111
  • [10] Case 32-2003: A 37-year-old woman with atypical squamous cells on a Papanicolaou smear - Atypical squamous cells of unknown significance (on the Papanicolaou smear), with a negative test for high-risk human papillomavirus. The patient is currently not at increased risk for cervical cancer
    Goodman, A
    Wilbur, DC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (16) : 1555 - 1564